Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Yahoo/Reuters
Monday, October 20, 2014 - 8:17am
tags:
Sanofi, Regeneron, dupilumab, eczema
Purdue Says Kentucky Suit Over OxyContin Could Be Painful
Bloomberg
Monday, October 20, 2014 - 8:15am
tags:
Purdue, oxycontin, Kentucky
A Promising Experimental Ebola Drug Goes Overlooked
Bloomberg/Businessweek
Monday, October 20, 2014 - 8:13am
tags:
ebola virus, Sarepta Therapeutics, AVI-7537
NewLink in $1 bln deal with Roche to develop cancer drug
Yahoo/Reuters
Monday, October 20, 2014 - 8:11am
tags:
NewLink Genetics, Roche, cancer immunotherapy
Pfizer/AZ chase may be off as pharma deals falter
CNBC
Monday, October 20, 2014 - 8:10am
tags:
Pfizer, AstraZeneca, M&A
This Drug Could Outsell Medical Marijuana
Motley Fool
Sunday, October 19, 2014 - 12:36pm
tags:
Gilead, Harvoni, Sovaldi, hepatitis C, Medical Marijuana
Shire may turn acquirer after AbbVie deal collapse
Seeking Alpha
Sunday, October 19, 2014 - 12:33pm
tags:
Shire, M&A, Cubist Pharma, NPS Pharmaceuticals
Latest Actos Bladder Cancer Trial Starts in West Virginia
Legal Examiner
Sunday, October 19, 2014 - 10:26am
tags:
Actos, Takeda, diabetes
Sexual Dysfunction Drugs For Women Are About Profit, Not Equality
Huffington Post
Sunday, October 19, 2014 - 10:23am
tags:
female sexual dysfunction
Better Late Than Never: CMS Improves The Doctor Payment Website
WSJ Pharmalot
Saturday, October 18, 2014 - 11:31am
tags:
CMS, Medicare, Medicaid, physician payments, Physician Payment Sunshine Act
MannKind: 5 Potential Technosphere Applications
Seeking Alpha
Saturday, October 18, 2014 - 10:49am
tags:
MannKind, Technosphere
Ebola Drug Race Ramps Up in Earnest
WSJ
Saturday, October 18, 2014 - 10:43am
tags:
Tekmira Pharmaceuticals, Mapp Biopharmaceutical, Chimerix, Ebola, vaccines
Proteon Therapeutics on deck for IPO
Seeking Alpha
Saturday, October 18, 2014 - 10:36am
tags:
Proteon Therapeutics, IPOs
Dept. of Irony: AbbVie Can Take Tax Write-Off for Fees On Busted Shire Deal
WSJ
Saturday, October 18, 2014 - 10:10am
tags:
AbbVie, Shire
Perrigo CEO Constructs "Five Pillars" For Success
Investor's.com
Saturday, October 18, 2014 - 10:09am
tags:
Perrigo
Ultragenyx Reports Data from Sialic Acid Deficiency Study
Yahoo/Zacks
Saturday, October 18, 2014 - 10:03am
tags:
Ultragenyx, SA-ER, hereditary inclusion body myopathy
Will ObamaCare Help McKesson, Other Drug Companies?
Investors.com
Friday, October 17, 2014 - 7:11pm
tags:
Affordable Care Act, McKesson, AmerisourceBergen, Cardinal Health
Gilead's Harvoni Receives Notice of Compliance from Canada
Yahoo/Zacks.com
Friday, October 17, 2014 - 7:08pm
tags:
Gilead Sciences, Harvoni, hepatitis C, Canada
Myriad Gets Reimbursement OK On Prostate Cancer Test
Investors.com
Friday, October 17, 2014 - 7:02pm
tags:
Myriad Genetics, prostate cancer, diagnostics, Medicare
Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit - sources
Yahoo/Reuters
Friday, October 17, 2014 - 6:49pm
tags:
Fresenius, Danone, medical nutrition, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.